Insider · CIK 0001213895

DESOUZA ERROL B

Reports to the SEC for 7 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001213895

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	98,650
2026-06-17	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2025-06-11	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2025-06-11	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	69,950
2025-05-13	RPRXRoyalty Pharma plcA Award	Director	AAward	+7,614 sh	—	—	81,352
2024-06-07	RPRXRoyalty Pharma plcA Award	Director	AAward	+9,293 sh	—	—	73,738
2024-03-19	ALECAlector, Inc.A Award	Director	AAward	+41.3K sh	—	—	41,250
2024-03-19	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.4K sh	—	—	19,420
2023-11-30	KRSAKorsana Biosciences, Inc.A Award	Director	AAward	+30K sh	—	—	30,000
2023-11-30	KRSAKorsana Biosciences, Inc.A Award	Director	AAward	+20K sh	—	—	50,000
2023-06-23	RPRXRoyalty Pharma plcA Award	Director	AAward	+7,747 sh	—	—	64,445
2022-06-24	RPRXRoyalty Pharma plcA Award	Director	AAward	+6,328 sh	—	—	56,698
2022-06-14	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-10-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+3,588 sh	—	—	29,801
2021-07-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+3,406 sh	—	—	26,213
2021-06-25	RPRXRoyalty Pharma plcA Award	Director	AAward	+5,726 sh	—	—	50,370
2021-06-24	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-04-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+2,926 sh	—	—	22,807
2021-01-05	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+2,129 sh	—	—	19,881
2020-10-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+3,125 sh	—	—	17,752
2020-07-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+2,129 sh	—	—	14,627
2020-06-18	RPRXRoyalty Pharma plcA Award	Director	AAward	+8,929 sh	—	—	44,644
2020-06-15	RPRXRoyalty Pharma plc · LP interests in RPI US Partners 2019, LPA Award	Director	AAward	+53.9K sh	—	—	53,915
2020-06-15	RPRXRoyalty Pharma plcA Award	Director	AAward	+35.7K sh	—	—	35,715
2020-06-11	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2020-04-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+2,860 sh	—	—	12,498
2020-01-02	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,835 sh	—	—	9,638
2019-10-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+2,545 sh	—	—	7,803
2019-07-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,810 sh	—	—	5,258
2019-06-13	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-04-01	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,504 sh	—	—	3,448
2018-12-31	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+1,703 sh	—	—	1,944
2018-06-13	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-02-20	GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteJ Other	Director	JOther	−4,679 sh	—	—	0
2018-02-20	GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteJ Other	Director	JOther	—	—	—	—
2017-07-13	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,750 sh	—	—	6,750
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,750 sh	—	—	6,750
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,250 sh	—	—	8,250
2015-09-30	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	Director, CEO	MExercise/Conversion	—	—	—	0
2015-09-30	ALBIREO PHARMA, INC.F Tax Payment	Director, CEO	FTax Payment	−43.5K sh	$0.44	−$19.1K	159,416
2015-09-30	ALBIREO PHARMA, INC.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+131K sh	—	—	202,885
2015-08-14	GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteA Award	Director	AAward	—	—	—	—
2014-12-19	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+225K sh	—	—	225,000
2014-12-11	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	—	—	15,333
2014-11-11	ALBIREO PHARMA, INC.Restricted Stock UnitsA Award	Director, CEO	AAward	+131K sh	—	—	131,128
2014-03-12	ALBIREO PHARMA, INC.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+5,625 sh	—	—	73,517
2014-03-12	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	Director, CEO	MExercise/Conversion	+5,625 sh	—	—	0

Recent filings

Accepted (ET)
Jun 174
DESOUZA ERROL B0001193125-26-274123
SEC(opens sec.gov)
Jun 124
DESOUZA ERROL B0000950170-25-085615
SEC(opens sec.gov)
May 144
DESOUZA ERROL B0001802768-25-000049
SEC(opens sec.gov)
Jun 104
DESOUZA ERROL B0001802768-24-000027
SEC(opens sec.gov)
Mar 214
DESOUZA ERROL B0000950170-24-034848
SEC(opens sec.gov)
Dec 44
DESOUZA ERROL B0000950170-23-067736
SEC(opens sec.gov)
Jun 264
DESOUZA ERROL B0001209191-23-039672
SEC(opens sec.gov)
Jun 244
DESOUZA ERROL B0000899243-22-024038
SEC(opens sec.gov)
Jun 164
DESOUZA ERROL B0001140361-22-023329
SEC(opens sec.gov)
Oct 54
DESOUZA ERROL B0001209191-21-059424
SEC(opens sec.gov)
Jul 24
DESOUZA ERROL B0001209191-21-044688
SEC(opens sec.gov)
Jun 294
DESOUZA ERROL B0000950103-21-009693
SEC(opens sec.gov)
Jun 284
DESOUZA ERROL B0001140361-21-022547
SEC(opens sec.gov)
Apr 54
DESOUZA ERROL B0001209191-21-025028
SEC(opens sec.gov)
Jan 64
DESOUZA ERROL B0001209191-21-002150
SEC(opens sec.gov)

Companies

Address

C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600

SOUTH SAN FRANCISCO, CA, 94080